| Vol. 11.11 – 24 March, 2022 |
| |
|
|
| Scientists used a transcriptomics-guided drug target discovery strategy using gene signatures of smoking-associated COPD and from mice chronically exposed to cigarette smoke, identifying druggable targets expressed in alveolar epithelial progenitors, of which they screened the function in lung organoids. [Science Advances] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers demonstrated that an anticorisin monoclonal antibody ameliorated lung fibrosis by significantly inhibiting acute exacerbation in the human transforming growth factorβ1 model and acute lung injury in the bleomycin model. [Nature Communications] |
|
|
|
| Given that COPD often shares structural features with Birt-Hogg-Dubé syndrome, scientists investigated the link between COPD, cigarette smoke exposure and folliculin gene expression. [Thorax] |
|
|
|
| Investigators discovered an increased allelic expression pattern accompanied by overexpression of human leucocyte antigen (HLA)-B gene in SARS-CoV-2-infected human lung epithelial cells. [European Journal of Human Genetics] |
| |
|
|
| Researchers uncovered that the depletion of ARAF promoted anchorage-independent growth and metastasis through activation of AKT signaling in a subset of lung cancer cells. [Science Advances] |
|
|
|
| The authors found that glucocorticoid receptor was present in cytoplasmic KRAS-containing complexes and inhibited the activation of wild-type and oncogenic KRAS in mouse embryonic fibroblasts and human lung cancer A549 cells. [Science Signaling] |
|
|
|
| Scientists revealed that the expression of AlkB homolog 5 (ALKBH5) was increased in NSCLC and increased expression of ALKBH5 worsened the prognosis of patients with NSCLC. [Cancer Gene Therapy] |
|
|
|
| The authors reported how nuclear factor erythroid 2-related factor 2 disruption led to collateral damage in the form of CRISPR-mediated exon skipping. [Gene Therapy] |
|
|
|
| Researchers performed GEO dataset analysis and identified that claudin1 was a critical regulator of epidermal growth factor receptor tyrosine kinase inhibitors resistance in NSCLC cells. [Cell Death Discovery] |
|
|
|
| Physiochemical properties, encapsulation efficiency, loading content and in vitro release kinetics of doxorubicin were assessed in Mucin 1 (MUC1) aptamer-functionalized PLA-PEG nanocarriers targeting lung cancer cells. [Scientific Reports] |
| |
|
|
|
| The authors discuss the molecular and immunological mechanisms involved in physical barrier disruption induced by major airborne pollutants and outline their implications in the pathogenesis of asthma and COPD. [European Respiratory Review] |
|
|
|
| Involvement of the cardiovascular system in COVID-19 has important consequences during recovery from infection and the development of long COVID. [Nature Cardiovascular Research] |
|
|
|
|
| Windtree Therapeutics, Inc. announced results from its Phase II study of lucinactant for patients with severe COVID-19 associated ARDS and lung injury. [Windtree Therapeutics, Inc.] |
|
|
|
| Lung Therapeutics, Inc. announced the successful completion of a Phase Ia clinical trial for LTI-03, a Caveolin-1-related peptide designed to treat idiopathic pulmonary fibrosis. [Lung Therapeutics, Inc] |
|
|
|
|
| May 1 – 4, 2022 Riviera Maya, Mexico |
|
|
|
|
|
| University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States |
|
|
|
| Genentech, Inc. – South San Francisco, California, United States |
|
|
|
| Gilead Sciences – Foster City, California, United States |
|
|
|
| Fred Hutchinson Cancer Research Center – Seattle, Washington, United States |
|
|
|
| Berlin Institute of Health – Berlin, Germany |
|
|
|
|